Nomura Holdings
ARRY

Nomura Holdings’s Array Biopharma Inc ARRY Stock Holding History

Nomura Holdings’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-51,453
Closed -$183K – 1464
2016
Q2 		$183K Buy
+51,453
New +$168K ﹤0.01% 1052
2016
Q1 		– Sell
-22,674
Closed -$95K – 2183
2015
Q4 		$95K Sell
22,674
-3,713
-14% -$16.9K ﹤0.01% 1712
2015
Q3 		$121K Sell
26,387
-54,569
-67% -$324K ﹤0.01% 1491
2015
Q2 		$586K Buy
+80,956
New +$597K ﹤0.01% 1206
2014
Q3 		– Sell
-14,066
Closed -$64K – 3182
2014
Q2 		$64K Buy
+14,066
New +$58.2K ﹤0.01% 2586
2014
Q1 		– Sell
-26,011
Closed -$129K – 3003
2013
Q4 		$129K Sell
26,011
-99,101
-79% -$540K ﹤0.01% 1809
2013
Q3 		$777K Buy
125,112
+74,812
+149% +$444K ﹤0.01% 1178
2013
Q2 		$228K Buy
+50,300
New +$271K ﹤0.01% 1770

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Nomura Holdings's ARRY Position: Q3 2016 in Review

Nomura Holdings sold out of Array Biopharma Inc (ARRY) in Q3 2016, closing a stake of 51,453 shares — an estimated $183K sold.

Nomura Holdings first reported a position in ARRY in Q2 2013 and held it in 8 quarters. The position peaked at $777K in Q3 2013. 170 funds tracked by Wall St. Rank hold ARRY as of Q3 2016.

  • Nomura Holdings reported no remaining Array Biopharma Inc position as of Q3 2016 after selling out during the quarter.
  • Nomura Holdings sold 51,453 Array Biopharma Inc shares in Q3 2016, an estimated $183K.
  • Nomura Holdings first reported a position in Array Biopharma Inc in Q2 2013 and held it in 8 quarters.
  • Nomura Holdings's Array Biopharma Inc position peaked at $777K in Q3 2013.
  • 170 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2016.

Based on Nomura Holdings's 13F filing for Q3 2016, filed 14 Nov 2016.